UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diet-Microbe-Host Interactions That Affect Gut Mucosal Integrity and Infection Resistance

Frontiers in immunology, 2019-08, Vol.10, p.1802

2019

Volltextzugriff (PDF)

The impact of maternal and early life malnutrition on health: a diet-microbe perspective

BMC medicine, 2020-05, Vol.18 (1), p.135-15, Article 135

2020

Volltextzugriff (PDF)

Over supplementation with vitamin B12 alters microbe-host interactions in the gut leading to accelerated Citrobacter rodentium colonization and pathogenesis in mice

Microbiome, 2023-02, Vol.11 (1), p.21-21, Article 21

2023

Volltextzugriff (PDF)

Consumption of the cell-free or heat-treated fractions of a pitched kefir confers some but not all positive impacts of the corresponding whole kefir

Frontiers in microbiology, 2022-11, Vol.13, p.1056526-1056526

2022

Volltextzugriff (PDF)

Jaboticaba (Myrciaria jaboticaba) powder consumption improves the metabolic profile and regulates gut microbiome composition in high-fat diet-fed mice

Biomedicine & pharmacotherapy, 2021-12, Vol.144, p.112314-112314, Article 112314

2021

Volltextzugriff (PDF)

The Gut Commensal Escherichia coli Aggravates High-Fat-Diet-Induced Obesity and Insulin Resistance in Mice

Applied and environmental microbiology, 2023-03, Vol.89 (3), p.e0162822-e0162822

2023

Volltextzugriff (PDF)

The Use of Disinfectant in Barn Cleaning Alters Microbial Composition and Increases Carriage of Campylobacter jejuni in Broiler Chickens

Applied and environmental microbiology, 2022-05, Vol.88 (10), p.e0029522-e0029522

2022

Volltextzugriff (PDF)

Kefir microbial composition is a deciding factor in the physiological impact of kefir in a mouse model of obesity

British journal of nutrition, 2021-01, Vol.125 (2), p.129-138

2021

Volltextzugriff (PDF)

Consumption of kefir made with traditional microorganisms resulted in greater improvements in LDL cholesterol and plasma markers of inflammation in males when compared to a commercial kefir: a randomized pilot study

Applied physiology, nutrition, and metabolism, 2023-09, Vol.48 (9), p.668-677

2023

Volltextzugriff (PDF)

Pea polyphenolics and hydrolysis processing alter microbial community structure and early pathogen colonization in mice

The Journal of nutritional biochemistry, 2019-05, Vol.67, p.101-110

2019

Volltextzugriff (PDF)

Bacterial resistance to antibiotic alternatives: a wolf in sheep's clothing?

Animal frontiers, 2018-04, Vol.8 (2), p.39-47

2018

Volltextzugriff (PDF)

Evorpacept (ALX148), a CD47-Blocking Myeloid Checkpoint Inhibitor, in Combination with Azacitidine and Venetoclax in Patients with Acute Myeloid Leukemia (ASPEN-05): Results from Phase 1a Dose Escalation Part

Blood, 2022-11, Vol.140 (Supplement 1), p.9046-9047

2022

Volltextzugriff (PDF)

Evorpacept plus enfortumab vedotin in patients (Pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Phase 1a dose escalation results

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.4575-4575

2024

Volltextzugriff (PDF)

Use of reconstituted kefir consortia to determine the impact of microbial composition on kefir metabolite profiles

Food research international, 2023-11, Vol.173, p.113467-113467, Article 113467

2023

Volltextzugriff (PDF)

ALX148 Enhances the Depth and Durability of Response to Multiple AML Therapies

Blood, 2020-11, Vol.136 (Supplement 1), p.15-16

2020

Volltextzugriff (PDF)

ALX148, a CD47 Blocker, in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma

Blood, 2020-11, Vol.136 (Supplement 1), p.13-14

2020

Volltextzugriff (PDF)

Evorpacept (ALX148), a CD47-Blocking Myeloid Checkpoint Inhibitor, in Combination with Azacitidine: A Phase 1 / 2 Study in Patients with Myelodysplastic Syndrome (ASPEN-02)

Blood, 2021-11, Vol.138 (Supplement 1), p.2601-2601

2021

Volltextzugriff (PDF)

Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics from a Phase I Study of PF-06863135, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Blood, 2019-11, Vol.134 (Supplement_1), p.1869-1869

2019

Volltextzugriff (PDF)

Kant and Frege : Existence as a second-level property

Kant-Studien, 2000, Vol.91 (2), p.165-177

FORGIE, J. W

2000

Volltextzugriff (PDF)

Abstract CT060: Phase 1 study of azacitidine in combination with evorpacept for higher-risk myelodysplastic syndrome (MDS)

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT060-CT060

2024

Volltextzugriff (PDF)

The Possibility of Theistic Experience

Religious studies, 1998-09, Vol.34 (3), p.317-323

FORGIE, J. WILLIAM

1998

Volltextzugriff (PDF)

How Is the Question 'Is Existence a Predicate?' Relevant to the Ontological Argument?

International journal for philosophy of religion, 2008-12, Vol.64 (3), p.117-133

Forgie, J. William

2008

Volltextzugriff (PDF)

Gassendi and Kant on Existence

Journal of the history of philosophy, 2007-10, Vol.45 (4), p.511-523

Forgie, William

2007

Volltextzugriff (PDF)

Kant and Existence: Critique of Pure Reason A 600/B 628

Kant-Studien, 2008-01, Vol.99 (1), p.1-12

FORGIE, J. William

2008

Volltextzugriff (PDF)

Revisions in Nepenthes following explorations of the Kemul Massif and the surrounding region in north-central Kalimantan, Borneo

Phytotaxa, 2019-02, Vol.392 (2), p.97

2019

Volltextzugriff (PDF)

1 – 25 von 255

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Englisch
(254)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Diet-Microbe-Host Interactions That Affect Gut Mucosal Integrity and Infection Resistance

The impact of maternal and early life malnutrition on health: a diet-microbe perspective

Over supplementation with vitamin B12 alters microbe-host interactions in the gut leading to accelerated Citrobacter rodentium colonization and pathogenesis in mice

Consumption of the cell-free or heat-treated fractions of a pitched kefir confers some but not all positive impacts of the corresponding whole kefir

Jaboticaba (Myrciaria jaboticaba) powder consumption improves the metabolic profile and regulates gut microbiome composition in high-fat diet-fed mice

The Gut Commensal Escherichia coli Aggravates High-Fat-Diet-Induced Obesity and Insulin Resistance in Mice

The Use of Disinfectant in Barn Cleaning Alters Microbial Composition and Increases Carriage of Campylobacter jejuni in Broiler Chickens

Kefir microbial composition is a deciding factor in the physiological impact of kefir in a mouse model of obesity

Consumption of kefir made with traditional microorganisms resulted in greater improvements in LDL cholesterol and plasma markers of inflammation in males when compared to a commercial kefir: a randomized pilot study

Pea polyphenolics and hydrolysis processing alter microbial community structure and early pathogen colonization in mice

Bacterial resistance to antibiotic alternatives: a wolf in sheep's clothing?

Evorpacept (ALX148), a CD47-Blocking Myeloid Checkpoint Inhibitor, in Combination with Azacitidine and Venetoclax in Patients with Acute Myeloid Leukemia (ASPEN-05): Results from Phase 1a Dose Escalation Part

Evorpacept plus enfortumab vedotin in patients (Pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Phase 1a dose escalation results

Use of reconstituted kefir consortia to determine the impact of microbial composition on kefir metabolite profiles

ALX148 Enhances the Depth and Durability of Response to Multiple AML Therapies

ALX148, a CD47 Blocker, in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma

Evorpacept (ALX148), a CD47-Blocking Myeloid Checkpoint Inhibitor, in Combination with Azacitidine: A Phase 1 / 2 Study in Patients with Myelodysplastic Syndrome (ASPEN-02)

Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics from a Phase I Study of PF-06863135, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Kant and Frege : Existence as a second-level property

Abstract CT060: Phase 1 study of azacitidine in combination with evorpacept for higher-risk myelodysplastic syndrome (MDS)

The Possibility of Theistic Experience

How Is the Question 'Is Existence a Predicate?' Relevant to the Ontological Argument?

Gassendi and Kant on Existence

Kant and Existence: Critique of Pure Reason A 600/B 628

Revisions in Nepenthes following explorations of the Kemul Massif and the surrounding region in north-central Kalimantan, Borneo

Suchergebnisse filtern